Opinion
Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration
In today's Pharmaceutical Executive Daily, Eli Lilly and Abbisko Therapeutics announce a new strategic research collaboration in which Abbisko will leverage its early-stage drug discovery platform to ...
In today's Pharmaceutical Executive Daily, the FDA announces Operation TrialBlazer, a pilot program aimed at cutting early-stage clinical trial timelines by six to 12 months as the US looks to reclaim ...
The rule released Thursday builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs in ...
CMS plans to cut what Medicare pays hospitals for drugs bought through the 340B program and push site-neutral payment into a new category of outpatient services, two proposals that together would pull ...
After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has ...
More than 2,600 hospitals now participate in the 340B program, up from around 50 when it first began over three decades ago.
A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...
Lawmaker proposes sweeping 340B reforms to increase transparency, tighten patient eligibility, and cap out-of-pocket costs for low-income patients.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...
Illinois lawmakers passed a bill to protect hospitals' access to discounted drugs through the federal 340B program. A second bill was passed requiring an audit to see how hospitals and clinics use ...
SPRINGFIELD, Ill. (WAND) — A plan heading to Gov. JB Pritzker's desk could help lower drug prices by regulating 340B contracts. The 340B drug pricing program was created in 1992 to improve access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results